Roger M. Nitsch, MD

Affiliations: 
Psychiatry Universität Zürich, Zürich, ZH, Switzerland 
Area:
Alzheimer’s disease, genetics
Website:
http://www.dpr.uzh.ch/aboutus/People/directors/nitsch.html
Google:
"Roger Nitsch"
Bio:

http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=96

http://www.neurimmune.com/index.php?page=187

Mean distance: 14.64 (cluster 11)
 
SNBCP
Cross-listing: Alzheimer's Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Rust R, Kirabali T, Grönnert L, et al. (2020) A Practical Guide to the Automated Analysis of Vascular Growth, Maturation and Injury in the Brain. Frontiers in Neuroscience. 14: 244
Kirabali T, Rigotti S, Siccoli A, et al. (2019) The amyloid-β degradation intermediate Aβ34 is pericyte-associated and reduced in brain capillaries of patients with Alzheimer's disease. Acta Neuropathologica Communications. 7: 194
Akhmedov A, Bonetti NR, Reiner MF, et al. (2018) Deleterious role of endothelial lectin-like oxidized low-density lipoprotein receptor-1 in ischaemia/reperfusion cerebral injury. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X18793266
Merlini M, Kirabali T, Kulic L, et al. (2018) Extravascular CD3+ T Cells in Brains of Alzheimer Disease Patients Correlate with Tau but Not with Amyloid Pathology: An Immunohistochemical Study. Neuro-Degenerative Diseases. 18: 49-56
Merlini M, Shi Y, Keller S, et al. (2016) Reduced nitric oxide bioavailability mediates cerebroarterial dysfunction independent of cerebral amyloid angiopathy in a mouse model of Alzheimer's disease. American Journal of Physiology. Heart and Circulatory Physiology. ajpheart.00607.2016
Sevigny J, Chiao P, Bussière T, et al. (2016) The antibody aducanumab reduces Aβ plaques in Alzheimer's disease. Nature. 537: 50-6
Merlini M, Wanner D, Nitsch RM. (2016) Tau pathology-dependent remodelling of cerebral arteries precedes Alzheimer's disease-related microvascular cerebral amyloid angiopathy. Acta Neuropathologica
Jelcic I, Combaluzier B, Jelcic I, et al. (2015) Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy. Science Translational Medicine. 7: 306ra150
Hyman BT, Growdon JH, Albers MW, et al. (2015) Massachusetts Alzheimer's Disease Research Center: Progress and challenges. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Spescha RD, Klohs J, Semerano A, et al. (2015) Post-ischaemic silencing of p66Shc reduces ischaemia/reperfusion brain injury and its expression correlates to clinical outcome in stroke. European Heart Journal. 36: 1590-600
See more...